L01E — Proteīnkināzes inhibitori
Proteīnkināzes inhibitori (PROTEIN KINASE INHIBITORS)
| Aktīvā viela | Zāļu nosaukumi |
|---|---|
| Abemaciclibum | Verzenios |
| Acalabrutinibum | Calquence |
| Afatinibum | Afatinib Lotus, Giotrif |
| Alectinibum | Alecensa |
| Alpelisibum | Piqray |
| Asciminibum | Scemblix |
| Aumolertinibum | Aumseqa |
| Avapritinibum | Ayvakyt |
| Axitinibum | Axitinib Accord, Axitinib Sandoz, Axitinib Stada, Inlyta |
| Binimetinibum | Mektovi |
| Bosutinibum | Bosulif, Bosutinib MSN |
| Brigatinibum | Alunbrig |
| Cabozantinibum | COMETRIQ, Cabometyx |
| Capivasertibum | Truqap |
| Capmatinibum | Tabrecta |
| Ceritinibum | Zykadia |
| Cobimetinibum | Cotellic |
| Crizotinibum | XALKORI |
| Dabrafenibum | Finlee, Tafinlar |
| Dacomitinibum | Vizimpro |
| Dasatinibum | Dasatinib Accord Healthcare, Dasatinib Norameda, Dasatinib Teva, Dasatinib Viatris, Dasatinib Zentiva, Sprycel |
| Duvelisibum | Copiktra |
| Encorafenibum | Braftovi |
| Entrectinibum | Rozlytrek |
| Erdafitinibum | Balversa |
| Erlotinibum | Erlotinib Sandoz, Erlotinib Viatris, Tarceva |
| Everolimusum | Afinitor, Everolimus Norameda, Everolimus Teva, Votubia |
| Fedratinibum | Inrebic |
| Fruquintinibum | FRUZAQLA |
| Futibatinibum | Lytgobi |
| Gefitinibum | Gefitinib Norameda, Iressa |
| Gilteritinibum | Xospata |
| Ibrutinibum | Imbruvica |
| Idelalisibum | Zydelig |
| Imatinibum | Glivec, Imatinib Accord, Imatinib Grindeks, Imatinib Inteli, Imatinib Teva, Itivas |
| Lapatinibum | Tyverb |
| Larotrectinibum | VITRAKVI |
| Lazertinibum | Lazcluze |
| Lenvatinibum | Kisplyx, Lenvatinib Sandoz, Lenvima |
| Lorlatinibum | Lorviqua |
| Midostaurinum | Rydapt |
| Mirdametinibum | Ezmekly |
| Momelotinibum | Omjjara |
| Neratinibum | Nerlynx |
| Nilotinibum | Krufton, Nilotinib Accord, Nilotinib Olpha, Nilotinib STADA, Nilotinib Teva, Nilotinib Viatris |
| Nintedanibum | Agarf, Nintedanib, Nintedanib Accord, Nintedanib Sandoz, Nintedanib Teva, Nintedanib TevaPharm |
| Osimertinibum | TAGRISSO |
| Palbociclibum | Ibrance, Palbociclib Viatris |
| Pazopanibum | Pazopanib Accord, Pazopanib Auxilia, Pazopanib Teva, Pazopanib Viatris, Pazopanib Zentiva, Votrient |
| Pemigatinibum | Pemazyre |
| Pirtobrutinibum | Jaypirca |
| Ponatinibum | Iclusig |
| Quizartinibum | Vanflyta |
| Regorafenibum | Stivarga |
| Repotrectinibum | Augtyro |
| Ribociclibum | Kisqali |
| Ripretinibum | QINLOCK |
| Ruxolitinibum | Jakavi, Ruxolitinib MSN |
| Selpercatinibum | RETSEVMO |
| Selumetinibum | Koselugo |
Kompensējamās zāles
Šajā grupā 35 ATĶ kodi ir NVD kompensējamo zāļu sarakstā. Saraksts spēkā no 01.07.2026.
NVD35izraksta speciālists
| ATĶ | Aktīvā viela | Kompensācija | Izrakstīšana |
|---|---|---|---|
| L01EA01 | Imatinibum | 100% | NVD |
| L01EA02 | Dasatinibum | 100% | NVD |
| L01EA03 | Nilotinibum | 100% | NVD |
| L01EA04 | Bosutinibum | 100% | NVD |
| L01EA06 | Asciminibum | 100% | NVD |
| L01EB01 | Gefitinibum | 100% | NVD |
| L01EB02 | Erlotinibum | 100% | NVD |
| L01EB03 | Afatinibum | 100% | NVD |
| L01EB04 | Osimertinibum | 100% | NVD |
| L01EC01 | Vemurafenibum | 100% | NVD |
| L01EC02 | Dabrafenibum | 100% | NVD |
| L01ED03 | Alectinibum | 100% | NVD |
| L01ED04 | Brigatinibum | 100% | NVD |
| L01ED05 | Lorlatinibum | 100% | NVD |
| L01EE01 | Trametinibum | 100% | NVD |
| L01EE02 | Cobimetinibum | 100% | NVD |
| L01EF01 | Palbociclibum | 100% | NVD |
| L01EF02 | Ribociclibum, Ribociclibum (Adjuvantā terapija) | 100% | NVD |
| L01EF03 | Abemaciclibum | 100% | NVD |
| L01EG02 | Everolimusum (izņemot medikamentu Votubia), Everolimusum (medikaments Votubia) | 100% | NVD |
| L01EJ01 | Ruxolitinibum | 100% | NVD |
| L01EK01 | Axitinibum | 100% | NVD |
| L01EL01 | Ibrutinibum | 100% | NVD |
| L01EL02 | Acalabrutinibum | 100% | NVD |
| L01EL03 | Zanubrutinibum | 100% | NVD |
| L01EM03 | Alpelisibum | 100% | NVD |
| L01EX01 | Sunitinibum | 100% | NVD |
| L01EX02 | Sorafenibum (C22.0), Sorafenibum (Nexavar) | 100% | NVD |
| L01EX03 | Pazopanibum | 100% | NVD |
| L01EX05 | Regorafenibum | 100% | NVD |
| L01EX07 | Cabozantinibum | 100% | NVD |
| L01EX08 | Lenvatinibum | 100% | NVD |
| L01EX09 | Nintedanibum | 100% | NVD |
| L01EX10 | Midostaurinum | 100% | NVD |
| L01EX14 | Entrectibinum | 100% | NVD |
Apakšgrupas
L01EA - BCR-ABL Tirozīnkināzes inhibitori
L01EB - Epidermālā augšanas faktora receptora (EGFR) tirozīnkināzes inhibitori
L01EC - B-Raf serīna-treonīna kināzes (BRAF) inhibitori
L01ED - Anaplastiskās limfomas kināzes (ALK) inhibitori
L01EE - Mitogēna aktivētās proteīnkināzes (MEK) inhibitori
L01EF - Ciklīnatkarīgās kināzes (CDK) inhibitori
L01EG - Rapamicīna mērķa receptors zīdītājiem (mTOR) kināzes inhibitori
L01EH - Cilvēka epidermālā augšanas faktora receptora 2 (HER2) tirozīnkināzes inhibitori
L01EJ - Janus kināzes (JAK) inhibitori
L01EK - Vaskulārā endotēlija augšanas faktora receptoru (VEGFR) tirozīnkināzes inhibitori
L01EL - Brutona tirozīnkināzes (BTK) inhibitors
L01EM - Fosfatidilinozitola-3-kināzes (Pi3K) inhibitori
L01EN - Fibroblastu augšanas faktora receptora (FGFR) tirozīna kināzes inhibitori
L01EP - Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors
L01EX - Citi proteīnkināzes inhibitori
Avots: Zāļu valsts aģentūras Zāļu reģistrs · ATĶ klasifikators: data.gov.lv · kompensācija: NVD kompensējamo zāļu saraksts